|
|
Introduced |
 |
|
|
|
|
| |
Strontium Ranelate & Intermediates |
|
|
|
Description |
|
|
|
| |
Osteoporosis is a condition in which bone loss occurs. Bone loss leads to weak brittle bones that can break easily, even during everyday activities. Breaks (fractures) of the spine or non-spine (e. g. Wrist and hip) are the most common type. There are many drugs and minerals that work to treat osteoporosis.
Strontium ranelate is a drug that decreases the chance of fractures by slowing the loss of bone and possibly by building new bone. It is a new drug and therefore its benefits and harms need to be known. Strontium ranelate is designed to make your bones stronger in two ways. It encourages your body to grow new bone and it slows the breakdown of old bone.
Its Intermediates:
1). Diethyl-3-oxo-pentanedionate CAS No: 105-50-0
2). C12H14N2O4S CAS No: 58168-20-0
3). C20H26N2O8S CAS NO: 58194-26-6
|
|
|
|
|
Contact Us |
|
|
|
| |
Company Name: |
|
|
Suzhou Oulit Biopharmaceutical Co., Ltd. |
| |
Company Address: |
|
|
Room 318, No. 1326, Road Bing He, Suzhou, Jiangsu, China |
| |
Telephone: |
|
|
86-512-68055878 |
| |
Full Name (Department): |
|
|
Leopold Zhang () |
|
|
|
|
|
[
